Form D · Biotechnology

Biophytis SA

Paris, I0 · CIK 0001768946

Offering snapshot reported Sep 23, 2026 · SEC filing

Reported sold
$2.6M
Offering amount: $2.6M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 15, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 23, 2026Initial$2,598,526No comparison3SEC filing
Mar 23, 2026Initial$1,584,275No comparison3SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$182K
Finders' fees
$0
Form D file number
021-598641

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Maxim Group, LLC120708

Source: Form D, filed Sep 23, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Claude Allary Director
Chiara Baccelli Executive
Edouard Bieth Executive
Nadine Coulm Director
Christophe Courtillat Executive
Pierre Dilda Executive
Waly Dioh Executive
Jean Mariani Director, Executive
Stanislas Veillet Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
14 Avenue De L'opera
Paris, I0, 75001
Phone: +33 1 44 37 23 00